Pharmafile Logo
Pharmafocus logo
Advanced Search

EU trailing as China moves ahead with master file plans

September 28, 2010
Manufacturing and Production API, China, EU, excipients

There has been progress in China on the development of drug master files for pharmaceutical ingredients and components, highlighting once …

News

Helvoet breaks ground on Indian packaging plant

September 28, 2010
Manufacturing and Production Helvoet, packaging

Helvoet Pharma of Belgium has started officially started construction of a new production facility in India that is scheduled to …

News

European Commission eyes pharma ethics

September 27, 2010
Research and Development, Sales and Marketing European Commission, corporate responsibility, ethics

The European Commission is to examine corporate responsibility in the pharmaceutical industry with the aim of developing a series of …

News

Late stage cancer drug failure for AstraZeneca

September 27, 2010
Sales and Marketing AstraZeneca, prostate cancer, zibotentan

AstraZeneca’s oncology pipeline has suffered a further blow after prostate cancer drug zibotentan failed to meet its primary endpoint of …

News

AZ’s antiplatelet recommended for European approval

September 27, 2010
Sales and Marketing Brilinta, Brilique, Brillinta, Possia

AstraZeneca’s oral antiplatelet treatment Brilique has received a positive opinion from a key European advisory committee. A marketing authorisation for …

News
Biotech company Amgen's headquarters

Glass flakes lead Amgen to order Epogen and Procrit recall

September 27, 2010
Manufacturing and Production Amgen, Centocor Ortho Biotech, Epogen, Procrit, manufacturing compliance, recalls

Amgen has taken what it describes as a precautionary measure and recalled lots of two of its erythropoietin-based products Epogen …

News

Andy Black reappointed as Kinapse Chief Executive

September 27, 2010
Kinapse

27 September, 2010London, UK   Andy Black reappointed as Kinapse Chief Executive The Board of Directors of Kinapse Ltd. today …

News
Press release

Dr Alan Palmer joins One Nucleus

September 27, 2010
Research and Development One Nucleus, apppointment, research and development

Cambridge, UK-based life sciences body One Nucleus has appointed Dr Alan Palmer as a director. Alan is co-founder and chief …

Appointment

Kinapse CEO stepping down

September 24, 2010
Kinapse

24 September, 2010London, UKThe Board of Directors of Kinapse Ltd. today announced that Co-founder Shalabh Kumar has stepped down as …

News
Press release

Matthew Newman joins Incuna

September 24, 2010
Medical Communications Incuna, appointment, medical communications

Oxford, UK-based digital healthcare agency Incuna has appointed Matthew Newman as creative director.Matthew will oversee the creative department at Incuna, …

Appointment

Europe committee rejects MS treatment Movectro

September 24, 2010
Sales and Marketing Cladribine, Merck Serono Movectro

The Europe Medicines Agency has rejected Merck Serono’s new multiple sclerosis treatment Movectro, saying its benefits do not outweigh its …

News

Gene-targeting asthma drugs within a decade

September 24, 2010
Research and Development asthma, genetic

Asthma treatments that target genetic variants found in people susceptible to the condition could be available within the next ten …

News

Novartis sells bladder treatment rights to Warner Chilcott

September 24, 2010
Sales and Marketing Enablex, Novartis, Warner Chilcott

Novartis is to sell the US rights to market its overactive bladder treatment Enablex to Warner Chilcott. Novartis will receive …

News

Woolley Pau appoints senior creative

September 24, 2010
Medical Communications Woolley Pau, appointment, medical communications

Iain Harrison has joined Woolley Pau as deputy creative director, bringing 24 years industry experience to the agency in a …

Appointment

Avandia withdrawn in Europe, but remains in US

September 24, 2010
Sales and Marketing Avandia, FDA, pharmacovigilance, safety

GSK’s diabetes drug Avandia is to be withdrawn from the market in Europe because of high levels of heart attack, …

News
Janssen's psoriasis social media campaign

Digital Pharma: Janssen unveils UK social media plans

September 23, 2010
Medical Communications Digital Pharma blog, Facebook, Janssen, Twitter, psoriasis, social media, youtube

Janssen UK is to launch a wide-ranging social media campaign to raise awareness of the chronic skin condition psoriasis. The …

News

Extra phase II studies boost GSK’s Relovair

September 23, 2010
COPD, GlaxoSmithKline, Relovair, asthma

GlaxoSmithKline has conducted additional phase II trials on its asthma/COPD drug Relovair to answer a number of safety and efficacy …

News
Pradaxa

FDA committee backs Pradaxa

September 23, 2010
Sales and Marketing Boehringer, Pradaxa, atrial fibrilation

An FDA committee has voted unanimously in favour of approving Pradaxa for stroke prevention in patients with atrial fibrillation. The …

News

Solid results for AstraZeneca’s oral RA drug

September 23, 2010
Research and Development AstraZeneca, Rigel, fostamatinib, rheumatoid arthritis

AstraZeneca’s new oral treatment for rheumatoid arthritis has produced solid results in a phase II trial. Fostamatinib is the first …

News

New Commercial Realities – Part 2: Key stakeholders in the changing healthcare environment

September 23, 2010
Sales and Marketing Kinapse, White paper

Feature
White paper
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026